<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Artemis Medicare Services Limited

NSE: ARTEMISMED · Healthcare

Artemis Medicare Services Limited Share Price & Analysis

270.27 -0.15%Updated 13 May 2026, 11:32 am IST
LTP
270.27
-0.15%
Open
High
273.71
Low
263.81
Close
₹270.27
52W High
₹298
52W Low
₹203
Volume
125K
Lot Size
1
Sector
Healthcare
Market Cap
₹4K Cr
Face Value
₹1
Small Cap

Price Chart

Fundamentals

P/E
39.7
Sector P/E
43.5
P/B
4.58
EPS
₹6.77
ROE
12%
ROCE
14.6%
D/E Ratio
0.28
Div Yield
0.17%
Book Value
₹59
+

Strengths

  • Low debt relative to equity (D/E 0.3x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
1,844
₹4.4L Cr36.55.6916.920.20.07
DIVISLAB
Divi's Laboratories Limited
6,711
₹1.8L Cr70.311.5515.420.40.01
TORNTPHARM
Torrent Pharmaceuticals Limited
4,358
₹1.5L Cr64.317.4326.5270.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,057
₹1.2L Cr64.112.7518.416.60.88
CIPLA
Cipla Limited
1,306
₹1.1L Cr22.93.217.822.70.01
LUPIN
Lupin Limited
2,238
₹1.1L Cr18.94.5629.130.30.32
DRREDDY
Dr. Reddy's Laboratories Limited
1,274
₹1.1L Cr19.42.951822.70.16

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

ARTEMISMED · as of Mar 2026

Promoters67.17%
FII0.31%0.34
DII5.04%0.53
Public20.39%0.20
Govt7.09%
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters68.03%68.03%67.51%67.17%67.17%67.17%
FII0.11%0.10%0.16%0.21%0.65%0.31%
DII1.96%2.61%3.45%3.60%4.51%5.04%
Public22.72%22.08%21.76%21.93%20.59%20.39%
Govt7.18%7.18%7.12%7.09%7.09%7.09%

Corporate Events

To consider and approve Audited Financial Results and recommendation of dividend, If any.

Dividend7 May 2026

Dividend - Re 0.45 Per Share

Dividend10 Jul 2025

Dividend - Rs 0.45 Per Share

Dividend4 Jul 2024

Dividend - Re 0.45 Per Share

Dividend13 Jul 2023

Financials

Quarterly Results

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
₹272 Cr
▼1.1%
₹275 Cr
▲7.8%
₹255 Cr
▲6.3%
₹240 Cr
▲3.4%
₹232 Cr
▼3.7%
₹241 Cr
▲8.1%
₹223 Cr
▼0.9%
₹225 Cr
Op. Profit
₹45 Cr
▼11.8%
₹51 Cr
▲24.4%
₹41 Cr
▲13.9%
₹36 Cr
▼2.7%
₹37 Cr
▼11.9%
₹42 Cr
▲16.7%
₹36 Cr
▼5.3%
₹38 Cr
OPM
16.0%
▼11.1%
18.0%
▲12.5%
16.0%
▲6.7%
15.0%
▼6.3%
16.0%
▼11.1%
18.0%
▲12.5%
16.0%
▼5.9%
17.0%
Net Profit
₹22 Cr
▼26.7%
₹30 Cr
▲42.9%
₹21 Cr
▼8.7%
₹23 Cr
▲9.5%
₹21 Cr
▼4.5%
₹22 Cr
▲29.4%
₹17 Cr
▲21.4%
₹14 Cr
EPS (₹)
1.41
▼34.7%
2.16
▲41.2%
1.53
▼8.4%
1.67
▲11.3%
1.5
▼7.4%
1.62
▲32.8%
1.22
▲17.3%
1.04

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Revenue
₹1.1K Cr
▲15.4%
₹937 Cr
▲6.6%
₹879 Cr
▲19.3%
₹737 Cr
▲32.8%
₹555 Cr
▲36.0%
₹408 Cr
▼27.8%
₹565 Cr
▲3.3%
₹547 Cr
Expenses
₹893 Cr
▲13.8%
₹785 Cr
▲5.2%
₹746 Cr
▲16.0%
₹643 Cr
▲32.0%
₹487 Cr
▲30.6%
₹373 Cr
▼25.8%
₹503 Cr
▲4.6%
₹481 Cr
Op. Profit
₹188 Cr
▲23.7%
₹152 Cr
▲14.3%
₹133 Cr
▲41.5%
₹94 Cr
▲38.2%
₹68 Cr
▲94.3%
₹35 Cr
▼43.5%
₹62 Cr
▼6.1%
₹66 Cr
OPM
17.0%
▲6.3%
16.0%
▲6.7%
15.0%
▲15.4%
13.0%
▲8.3%
12.0%
▲33.3%
9.0%
▼18.2%
11.0%
▼8.3%
12.0%
Other Income
₹27 Cr
▼18.2%
₹33 Cr
▲371.4%
₹7 Cr
▲0.0%
₹7 Cr
▲133.3%
₹3 Cr
▼57.1%
₹7 Cr
▲75.0%
₹4 Cr
▲100.0%
₹2 Cr
Interest
₹28 Cr
▼12.5%
₹32 Cr
▲3.2%
₹31 Cr
▲55.0%
₹20 Cr
▲66.7%
₹12 Cr
▼7.7%
₹13 Cr
▲0.0%
₹13 Cr
▲18.2%
₹11 Cr
Depreciation
₹48 Cr
▲6.7%
₹45 Cr
▲12.5%
₹40 Cr
▲29.0%
₹31 Cr
▲40.9%
₹22 Cr
▲0.0%
₹22 Cr
▼4.3%
₹23 Cr
▲15.0%
₹20 Cr
PBT
₹139 Cr
▲28.7%
₹108 Cr
▲58.8%
₹68 Cr
▲33.3%
₹51 Cr
▲37.8%
₹37 Cr
▲362.5%
₹8 Cr
▼74.2%
₹31 Cr
▼16.2%
₹37 Cr
Tax %
25.0%
▲4.2%
24.0%
▼14.3%
28.0%
▲12.0%
25.0%
▲56.3%
16.0%
▼11.1%
18.0%
▼50.0%
36.0%
▼20.0%
45.0%
Net Profit
₹104 Cr
▲26.8%
₹82 Cr
▲67.3%
₹49 Cr
▲28.9%
₹38 Cr
▲22.6%
₹31 Cr
▲416.7%
₹6 Cr
▼68.4%
₹19 Cr
▼5.0%
₹20 Cr
EPS (₹)
6.55
▲9.2%
6
▲65.7%
3.62
▲25.7%
2.88
▲20.0%
2.4
▲389.8%
0.49
▼67.1%
1.49
▲53.6%
0.97
Div Payout
7.0%
▲0.0%
7.0%
▼41.7%
12.0%
▼25.0%
16.0%
0.0%
0.0%
0.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Sep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Liabilities
Equity Capital
₹16 Cr
▲14.3%
₹14 Cr
▲0.0%
₹14 Cr
▲0.0%
₹14 Cr
▲7.7%
₹13 Cr
▲0.0%
₹13 Cr
▲0.0%
₹13 Cr
▲0.0%
₹13 Cr
▲0.0%
₹13 Cr
Reserves
₹919 Cr
▲5.8%
₹869 Cr
▲5.5%
₹824 Cr
▲89.4%
₹435 Cr
▲11.5%
₹390 Cr
▲12.7%
₹346 Cr
▲12.7%
₹307 Cr
▲2.3%
₹300 Cr
▲7.1%
₹280 Cr
Borrowings
₹262 Cr
▼6.1%
₹279 Cr
▼3.8%
₹290 Cr
▼9.4%
₹320 Cr
▲11.9%
₹286 Cr
▲42.3%
₹201 Cr
▲36.7%
₹147 Cr
▲30.1%
₹113 Cr
▼0.9%
₹114 Cr
Other Liabilities
₹232 Cr
▼12.1%
₹264 Cr
▲15.3%
₹229 Cr
▲12.8%
₹203 Cr
▼6.0%
₹216 Cr
▲45.0%
₹149 Cr
▲12.0%
₹133 Cr
▼16.9%
₹160 Cr
▲8.8%
₹147 Cr
Total Liabilities
₹1.4K Cr
▲0.2%
₹1.4K Cr
▲5.1%
₹1.4K Cr
▲39.6%
₹972 Cr
▲7.4%
₹905 Cr
▲27.5%
₹710 Cr
▲18.3%
₹600 Cr
▲2.4%
₹586 Cr
▲5.8%
₹554 Cr
Assets
Fixed Assets
₹805 Cr
▲1.4%
₹794 Cr
▲6.6%
₹745 Cr
▲3.6%
₹719 Cr
▲18.8%
₹605 Cr
▲23.7%
₹489 Cr
▲27.7%
₹383 Cr
▼2.5%
₹393 Cr
▲3.1%
₹381 Cr
CWIP
₹28 Cr
▼20.0%
₹35 Cr
▼12.5%
₹40 Cr
▲21.2%
₹33 Cr
▼65.3%
₹95 Cr
▲48.4%
₹64 Cr
▼21.0%
₹81 Cr
▲44.6%
₹56 Cr
▲14.3%
₹49 Cr
Investments
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
Other Assets
₹596 Cr
▼0.2%
₹597 Cr
▲4.4%
₹572 Cr
▲161.2%
₹219 Cr
▲6.8%
₹205 Cr
▲30.6%
₹157 Cr
▲15.4%
₹136 Cr
▼0.7%
₹137 Cr
▲10.5%
₹124 Cr
Total Assets
₹1.4K Cr
▲0.2%
₹1.4K Cr
▲5.1%
₹1.4K Cr
▲39.6%
₹972 Cr
▲7.4%
₹905 Cr
▲27.5%
₹710 Cr
▲18.3%
₹600 Cr
▲2.4%
₹586 Cr
▲5.8%
₹554 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operating CF
₹132 Cr
▼9.6%
₹146 Cr
▲33.9%
₹109 Cr
▼14.2%
₹127 Cr
▲111.7%
₹60 Cr
▲122.2%
₹27 Cr
▼51.8%
₹56 Cr
▲40.0%
₹40 Cr
Investing CF
₹-90 Cr
▲76.6%
₹-385 Cr
▼337.5%
₹-88 Cr
▲44.3%
₹-158 Cr
▼47.7%
₹-107 Cr
▼189.2%
₹-37 Cr
▼42.3%
₹-26 Cr
▲48.0%
₹-50 Cr
Financing CF
₹-50 Cr
▼118.7%
₹267 Cr
▲1020.7%
₹-29 Cr
▼176.3%
₹38 Cr
▼13.6%
₹44 Cr
▲144.4%
₹18 Cr
▲166.7%
₹-27 Cr
▼292.9%
₹14 Cr
Net Cash Flow
₹-8 Cr
▼129.6%
₹27 Cr
▲437.5%
₹-8 Cr
▼214.3%
₹7 Cr
▲333.3%
₹-3 Cr
▼137.5%
₹8 Cr
▲300.0%
₹2 Cr
▼60.0%
₹5 Cr
Free Cash Flow
₹32 Cr
▼41.8%
₹55 Cr
▲48.6%
₹37 Cr
▲305.6%
₹-18 Cr
▲63.3%
₹-49 Cr
▼1125.0%
₹-4 Cr
▼113.3%
₹30 Cr
▲276.5%
₹-17 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debtor Days
40d
▲2.6%
39d
▲0.0%
39d
▼15.2%
46d
▼4.2%
48d
▼2.0%
49d
▲0.0%
49d
▼5.8%
52d
Inventory Days
Days Payable
Cash Conv. Cycle
40d
▲2.6%
39d
▲0.0%
39d
▼15.2%
46d
▼4.2%
48d
▼2.0%
49d
▲0.0%
49d
▼5.8%
52d
Working Capital Days
-17d
▲39.3%
-28d
▼3.7%
-27d
▲37.2%
-43d
▼65.4%
-26d
▲27.8%
-36d
▲0.0%
-36d
▲29.4%
-51d
ROCE
15.0%
▲0.0%
15.0%
▲7.1%
14.0%
▲27.3%
11.0%
▲10.0%
10.0%
▲150.0%
4.0%
▼60.0%
10.0%

Source: Screener.in · Lower days = better efficiency

About Artemis Medicare Services Limited

Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. [1][2]

Healthcare · Healthcare Services

Frequently Asked Questions

What is Artemis Medicare Services Limited share price today?
Artemis Medicare Services Limited (ARTEMISMED) is currently trading at ₹270.27 on NSE, down 0.15% as of the last market session. Prices update daily after market close on MarketNetra.
Is Artemis Medicare Services Limited available in F&O (Futures & Options)?
Yes, Artemis Medicare Services Limited (ARTEMISMED) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Artemis Medicare Services Limited 52-week high and low?
Artemis Medicare Services Limited's 52-week high is ₹298 and the 52-week low is ₹203. The current price of ₹270.27 is 9.3% below the 52W high.
What is Artemis Medicare Services Limited P/E ratio?
Artemis Medicare Services Limited's current P/E ratio is 39.7. This indicates the market is paying ₹39.7 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Artemis Medicare Services Limited options?
Artemis Medicare Services Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ARTEMISMED options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.